OptoSeeker Biotech, a pioneer in advanced life science instrumentation, today announced its inclusion in the prestigious "2025 Venture 50" China Life Sciences List. Released jointly by Zero2IPO Group and ChinaVenture, the list recognizes OptoSeeker for its robust technological capabilities and exceptional commercial potential, selecting the company from a competitive pool of tens of thousands of enterprises nationwide.

Recently, breakthrough research enabled by OptoSeeker Biotech’s flagship product, the OptoBot®500 Optoelectronic Tweezer System, was published in Laser & Photonics Reviews, an internationally renowned journal in laser science and photonics. The study, titled “Tuning Self-Assembled Topological Dipoles in Optoelectronic Traps,” highlights a major advancement in light-controlled topological self-assembly.

This publication marks the first time OptoSeeker Biotech’s DropletBot® Digital Microfluidic Platform has supported researchers in reaching JACS, underscoring the system’s innovation and international recognition in next-generation biomolecular detection.

Subsequent to the successful conclusion of the 18th Pujiang Innovation Forum, the official roster of accolades for the 2025 InnoMatch Technology Transfer Convention was formally unveiled. Optoseeker Biotech was successfully conferred the esteemed "Innovation Vigor Rising Star Award" in overt recognition of the pivotal technological advancements, industrial conversion potential, and profound application merits of its instrumentation within the high-end life science domain.

The HICOOL 2025 Global Entrepreneur Summit officially opened on October 16th at the Beijing International Convention and Exhibition Center. As a highly anticipated international innovation and entrepreneurship platform, the HICOOL Competition has consistently dedicated itself to converging global intelligence and promoting the integration of cutting-edge technology and industry. In this year's competition, OptoSeeker Biotech, leveraging its solid technical foundation and clear industrialization pathway, distinguished itself amidst fierce competition and successfully secured the Third Prize in the HICOOL 2025 Global Entrepreneur Competition.

OptoSeeker Biotech and the National Major Science and Technology Infrastructure for Translational Medicine (Sichuan)/State Key Laboratory of Biotherapy at Sichuan University have officially launched a "Single-Cell Optofluidic Intelligent Screening Joint Demonstration Laboratory" in Chengdu.